Mark J. Foley - Mar 6, 2024 Form 4 Insider Report for Revance Therapeutics, Inc. (RVNC)

Role
CEO, Director
Signature
/s/ Dwight Moxie, Attorney-in-Fact
Stock symbol
RVNC
Transactions as of
Mar 6, 2024
Transactions value $
$209,400
Form type
4
Date filed
3/8/2024, 04:33 PM
Previous filing
Mar 4, 2024
Next filing
Mar 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVNC Common Stock Purchase $209K +30K +3.04% $6.98 1.02M Mar 6, 2024 Direct F1
holding RVNC Common Stock 111K Mar 6, 2024 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person purchased shares of common stock in an underwritten public offering by the issuer that closed on March 6, 2024.
F2 These shares are held by the Mark and Dana Foley, Trustees, Foley Family Trust U/A DTD 4/10/2002.